Literature DB >> 26457240

MicroRNA-Specificity Protein (Sp) Transcription Factor Interactions and Significance in Carcinogenesis.

Stephen Safe1.   

Abstract

Specificity protein (Sp) transcription factors (TFs) such as Sp1, Sp3 and Sp4 are overexpressed in tumors and Sp1 is a negative prognostic factor for multiple tumor types. Sp TFs regulate expression of pro-oncogenic factors important for cell proliferation, survival, angiogenesis, migration/invasion and inflammation and the high expression of Sp TFs in tumors is primarily due to miRNAs. For example, expression of tumor-suppressor-like miRNAs such as miR-200b/c, miR-335, miR-22, miR-149 and others that inactivate Sp1 expression is low in many tumor types. Research in our laboratory has also demonstrated that high expression of Sp TFs is also due to miRNA-dependent inhibition of the transcriptional repressors ZBTB10 and ZBTB4 by miR-27a and miR-20a/miR-17p, respectively. Thus, miRNAs play a critical role in maintaining high levels of Sp1, Sp3, Sp4 and pro-oncogenic Sp-regulated genes in tumors and cancer cells, and there is ample evidence that anticancer agents targeting the miRNASp TF axis can be highly effective for cancer chemotherapy.

Entities:  

Keywords:  Sp TFs regulation; Sp1; Sp3; Sp4; miR-20a/miR-17-5p:ZBTB4; miR-27a:ZBT10; miRNAs inhibit Sp TFs; specificity protein transcription factors (Sp TFs)

Year:  2015        PMID: 26457240      PMCID: PMC4596546          DOI: 10.1007/s40495-014-0012-8

Source DB:  PubMed          Journal:  Curr Pharmacol Rep        ISSN: 2198-641X


  75 in total

1.  Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

Authors:  Guido Marcucci; Kati Maharry; Michael D Radmacher; Krzysztof Mrózek; Tamara Vukosavljevic; Peter Paschka; Susan P Whitman; Christian Langer; Claudia D Baldus; Chang-Gong Liu; Amy S Ruppert; Bayard L Powell; Andrew J Carroll; Michael A Caligiuri; Jonathan E Kolitz; Richard A Larson; Clara D Bloomfield
Journal:  J Clin Oncol       Date:  2008-09-22       Impact factor: 44.544

2.  Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.

Authors:  Satya S Pathi; Ping Lei; Sandeep Sreevalsan; Gayathri Chadalapaka; Indira Jutooru; Stephen Safe
Journal:  Nutr Cancer       Date:  2011-09-15       Impact factor: 2.900

Review 3.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 4.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

5.  The miR-17-92 microRNA cluster is regulated by multiple mechanisms in B-cell malignancies.

Authors:  Ming Ji; Enyu Rao; Himabindu Ramachandrareddy; Yulei Shen; Chunsun Jiang; Jianxiu Chen; Yiqiao Hu; Angie Rizzino; Wing C Chan; Kai Fu; Timothy W McKeithan
Journal:  Am J Pathol       Date:  2011-07-30       Impact factor: 4.307

6.  Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.

Authors:  Gayathri Chadalapaka; Indira Jutooru; Robert Burghardt; Stephen Safe
Journal:  Mol Cancer Res       Date:  2010-04-20       Impact factor: 5.852

7.  Role of microRNAs in drug-resistant ovarian cancer cells.

Authors:  Antonio Sorrentino; Chang-Gong Liu; Antonio Addario; Cesare Peschle; Giovanni Scambia; Cristiano Ferlini
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

8.  YY1 and Sp1 transcription factors bind the human transferrin gene in an age-related manner.

Authors:  G S Adrian; E Seto; K S Fischbach; E V Rivera; E K Adrian; D C Herbert; C A Walter; F J Weaker; B H Bowman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-01       Impact factor: 6.053

9.  Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition.

Authors:  Natasha Kolesnikoff; Joanne L Attema; Suraya Roslan; Andrew G Bert; Quenten P Schwarz; Philip A Gregory; Gregory J Goodall
Journal:  J Biol Chem       Date:  2014-03-13       Impact factor: 5.157

10.  MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1.

Authors:  Y Xu; F Zhao; Z Wang; Y Song; Y Luo; X Zhang; L Jiang; Z Sun; Z Miao; H Xu
Journal:  Oncogene       Date:  2011-08-08       Impact factor: 9.867

View more
  8 in total

1.  High-level Sp1 is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma.

Authors:  Yi-Ting Chen; Hung-Pei Tsai; Chun-Chieh Wu; Chiao-Yun Chen; Chee-Yin Chai; Aij-Lie Kwan
Journal:  Pathol Oncol Res       Date:  2018-06-09       Impact factor: 3.201

Review 2.  Epigenetic regulation in dental pulp inflammation.

Authors:  T Hui; C Wang; D Chen; L Zheng; D Huang; L Ye
Journal:  Oral Dis       Date:  2016-03-28       Impact factor: 3.511

3.  A self-attention model for inferring cooperativity between regulatory features.

Authors:  Fahad Ullah; Asa Ben-Hur
Journal:  Nucleic Acids Res       Date:  2021-07-21       Impact factor: 16.971

4.  MiR-448 promotes glycolytic metabolism of gastric cancer by downregulating KDM2B.

Authors:  Xuehui Hong; Yang Xu; Xingfeng Qiu; Yuekun Zhu; Xing Feng; Zhijie Ding; Shifeng Zhang; Lifeng Zhong; Yifan Zhuang; Chen Su; Xinya Hong; Jianchun Cai
Journal:  Oncotarget       Date:  2016-04-19

Review 5.  The Role of the Ubiquitously Expressed Transcription Factor Sp1 in Tissue-specific Transcriptional Regulation and in Disease.

Authors:  Leigh O'Connor; Jane Gilmour; Constanze Bonifer
Journal:  Yale J Biol Med       Date:  2016-12-23

6.  Differentially Expressed MicroRNAs in the Development of Early Diabetic Retinopathy.

Authors:  Qiaoyun Gong; Jia'nan Xie; Yang Liu; Ying Li; Guanfang Su
Journal:  J Diabetes Res       Date:  2017-06-15       Impact factor: 4.011

7.  GATA4 promotes hepatoblastoma cell proliferation by altering expression of miR125b and DKK3.

Authors:  Yihua Pei; Qin Yao; Sibo Yuan; Bozhen Xie; Yan Liu; Chunsheng Ye; Huiqin Zhuo
Journal:  Oncotarget       Date:  2016-11-22

Review 8.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.